Colorectal Cancer Trial, Recruiting NCT07512232 Sponsor: Sun Yat-sen University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07512232
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People who have been diagnosed with a specific type of rectal cancer (rectal adenocarcinoma) confirmed by laboratory testing
  • People whose rectal tumor is located in the middle to lower part of the rectum, within 10 cm of the anal opening
  • People who have had keyhole (laparoscopic) surgery to remove their rectal cancer while preserving the sphincter muscle
  • People who do not have multiple different cancers occurring at the same time
  • People whose organs (such as liver and kidneys) are functioning adequately
  • People, or their family members, who are able to understand the study information and are willing to provide written consent to participate

Who may not be able to join:

  • People who currently have, or have previously had, another type of cancer
  • People who had a type of surgery that removed the rectum and anus entirely (called abdominoperineal resection), or a surgery where the bowel was diverted without reconnection (Hartmann's procedure)
  • People where a specific part of the abdominal lining was not opened during their surgery (confirm with trial site)
  • People who have previously had surgery on the pelvic floor
  • People who required emergency surgery because of a bowel blockage
  • People with serious liver, kidney, heart, lung, or blood-clotting problems, or other serious health conditions that the treating doctor determines would make the procedure unsafe
  • People with a history of severe mental health disorders
  • Women who are pregnant or breastfeeding
  • People considered unsuitable for any other clinical or medical reason, as determined by the trial investigators

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 15989101216

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 May 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Postoperative local recurrence rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov